Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0G7BR
|
||||
| Former ID |
DIB007841
|
||||
| Drug Name |
AMAP-102
|
||||
| Synonyms |
5-HT antagonist (rheumatism), AnaMar
|
||||
| Indication | Arthritis [ICD9: 710-719; ICD10:M00-M25] | Phase 1 | [1] | ||
| Company |
AnaMar Medical AB
|
||||
| Target and Pathway | |||||
| Target(s) | 5-HT 2 receptor | Target Info | Antagonist | [2] | |
| KEGG Pathway | Calcium signaling pathway | ||||
| Neuroactive ligand-receptor interaction | |||||
| Gap junction | |||||
| Serotonergic synapse | |||||
| Inflammatory mediator regulation of TRP channels | |||||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00995605) AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects. U.S. National Institutes of Health. | ||||
| REF 2 | Clinical pipeline report, company report or official report of Anamar. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.